Reconciled ClinicalTrials.gov v2 Protocol Specification
| Protocol Field | Verified Registry Value |
|---|---|
| NCT Identifier | NCT07699939 |
| Consolidated Lead Sponsor | National Cancer Center, Japan |
| Therapeutic Condition Cohort | Oncology and Hematology |
| Clinical Trial Phase | Phase II |
| Overall Recruitment Status | RECRUITING |
| Registered Enrollment | 136 participants (ESTIMATED) |
| Registered Start Date | 2026-07-15 |
| WhyStopped Classification | Not Stopped |
Named U.S. Hospital Clinical Research Sites
| Hospital Research Site | Location | Site Profile |
|---|---|---|
| Chiba Cancer Center | Chiba, Japan | Open Hospital Dossier -> |
| Hiroshima University Hospital | Hiroshima, Japan | Open Hospital Dossier -> |
| Osaka International Cancer Institute | Osaka, Japan | Open Hospital Dossier -> |
Search related sites and sponsors in the Interactive Directory, explore Oncology and Hematology Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.